This satellite aims to move forward the dialogue on including pregnant women in HIV clinical trials. We will have a rich discussion with a panel of community leaders and will hear feedback from a series of meetings convened over the past two years by the WHO and IMPAACT focused on approaches to enhance and accelerate study of new drugs for HIV and associated infections in pregnant women. These meetings brought together women living with HIV, academic researchers, clinical experts, regulators, industry, funders, and other key stakeholders involved in studying HIV-related drugs in pregnant women, with the goal of defining how we can achieve a paradigm shift in creating timely, high-quality data about new HIV drugs used in pregnancy.

• Presentations
• Session recording